Chevy Chase Trust Holdings, Inc. Abb Vie Inc. Transaction History

Chevy Chase Trust Holdings, Inc.

$33.7 Billion
Q2 2025

A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 962,268 shares of ABBV stock, worth $191 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

962,268

Previous 957,278 0.52%

Holding current value

$191 Million

Previous $201 Million 10.94%

% of portfolio

0.53%

Previous 0.65%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	BUY	$170.16 - $206.27 $849,098 - $1.03 Million	4,990 Added 0.52%	962,268 $179 Million
Q1 2025 Apr 23, 2025	SELL	$169.2 - $216.66 $676,969 - $866,856	-4,001 Reduced 0.42%	957,278 $201 Million
Q4 2024 Jan 30, 2025	SELL	$164.99 - $203.87 $3.35 Million - $4.14 Million	-20,317 Reduced 2.07%	961,279 $171 Million
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $2.56 Million - $3.11 Million	-15,603 Reduced 1.56%	981,596 $194 Million
Q2 2024 Jul 22, 2024	SELL	$154.79 - $180.76 $2.21 Million - $2.58 Million	-14,283 Reduced 1.41%	997,199 $171 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $1.42 Million - $1.62 Million	-8,884 Reduced 0.87%	1,011,482 $184 Million
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $1.78 Million - $2.01 Million	-12,949 Reduced 1.25%	1,020,366 $158 Million
Q3 2023 Oct 23, 2023	SELL	$133.59 - $154.65 $3.24 Million - $3.75 Million	-24,230 Reduced 2.29%	1,033,315 $154 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $1.93 Million - $2.4 Million	-14,580 Reduced 1.36%	1,057,545 $142 Million
Q1 2023 May 17, 2023	BUY	$144.61 - $166.54 $150 Million - $173 Million	1,040,498 Added 3289.9%	1,072,125 $171 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $149 Million - $172 Million	-1,030,187 Reduced 97.02%	31,627 $5.04 Billion
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $8.54 Million - $10.2 Million	-61,737 Reduced 5.49%	1,061,814 $172 Million
Q3 2022 Nov 04, 2022	BUY	$134.21 - $153.93 $1.67 Million - $1.91 Million	12,408 Added 1.12%	1,123,551 $151 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $587,499 - $746,904	4,269 Added 0.39%	1,111,143 $170 Million
Q1 2022 Apr 27, 2022	BUY	$131.98 - $163.75 $152,436 - $189,131	1,155 Added 0.1%	1,106,874 $179 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $2.39 Million - $3.02 Million	-22,219 Reduced 1.97%	1,105,719 $150 Million
Q3 2021 Oct 20, 2021	SELL	$106.4 - $120.78 $4.55 Million - $5.16 Million	-42,718 Reduced 3.65%	1,127,938 $122 Million
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $6.46 Million - $7.19 Million	-61,383 Reduced 4.98%	1,170,656 $132 Million
Q1 2021 Apr 22, 2021	SELL	$102.3 - $112.62 $6.92 Million - $7.62 Million	-67,632 Reduced 5.2%	1,232,039 $133 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $4.83 Million - $6.52 Million	-59,976 Reduced 4.41%	1,299,671 $139 Million
Q3 2020 Nov 06, 2020	SELL	$85.91 - $100.83 $11.8 Million - $13.8 Million	-136,895 Reduced 9.15%	1,359,647 $119 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $12.2 Million - $16.3 Million	166,521 Added 12.52%	1,496,542 $147 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $1.14 Million - $1.73 Million	17,736 Added 1.35%	1,330,021 $101 Million
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $258,802 - $323,817	-3,588 Reduced 0.27%	1,312,285 $116 Million
Q3 2019 Nov 20, 2019	SELL	$62.98 - $75.72 $258,029 - $310,224	-4,097 Reduced 0.31%	1,315,873 $99.6 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $154,526 - $197,520	-2,352 Reduced 0.18%	1,319,970 $96 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $755,123 - $888,743	-9,789 Reduced 0.73%	1,322,322 $105 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $3.05 Million - $3.76 Million	-39,195 Reduced 2.86%	1,332,111 $123 Million
Q3 2018 Oct 23, 2018	SELL	$88.91 - $98.84 $2.87 Million - $3.19 Million	-32,271 Reduced 2.3%	1,371,306 $130 Million
Q2 2018 Aug 02, 2018	SELL	$89.78 - $106.23 $6.24 Million - $7.39 Million	-69,543 Reduced 4.72%	1,403,577 $130 Million
Q1 2018 Apr 10, 2018	SELL	$92.01 - $123.21 $2.65 Million - $3.55 Million	-28,773 Reduced 1.92%	1,473,120 $139 Million
Q4 2017 Jan 22, 2018	SELL	$89.56 - $98.21 $1.05 Million - $1.15 Million	-11,675 Reduced 0.77%	1,501,893 $145 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $106 Million - $135 Million	1,513,568	1,513,568 $134 Million

Others Institutions Holding ABBV

# of Institutions

4,241

Shares Held

1.28B

Call Options Held

16.2M

Put Options Held

14.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $351B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.

Account

Chevy Chase Trust Holdings, Inc. Abb Vie Inc. Transaction History